| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/10/2013 | CN101411532B Beverage containing natural medicament leaf of Toxicodendron vernicifluum and sealwort compositions and preparation method thereof |
| 04/10/2013 | CN101342207B Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia, hyperlipemia and preparation method thereof |
| 04/09/2013 | US8415384 Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade |
| 04/09/2013 | US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/09/2013 | US8415293 Peptide mediators of cholesterol efflux |
| 04/09/2013 | US8414924 Preparation for treating heart disease used in cell therapy |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | US8414891 Method for treating pulmonary hypertension |
| 04/09/2013 | CA2695605C Pyrazolone derivative emulsion formulations |
| 04/09/2013 | CA2642537C Vasodilator |
| 04/09/2013 | CA2566431C Process for the preparation of telmisartan |
| 04/09/2013 | CA2488230C Inositol pyrophosphates, and methods of use thereof |
| 04/09/2013 | CA2451116C Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 04/09/2013 | CA2350028C A method to improve circulation to ischemic tissue |
| 04/04/2013 | WO2013049617A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | WO2013049293A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049289A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013048402A1 Thrombopoietin receptor ligands for neuroprotection |
| 04/04/2013 | WO2013047701A1 Phenyl derivative |
| 04/04/2013 | WO2013047128A1 Peptide and angiotensin-converting enzyme inhibitor |
| 04/04/2013 | WO2013047055A1 Heat shock protein expression inducer |
| 04/04/2013 | WO2013046045A1 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
| 04/04/2013 | WO2013045380A2 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 04/04/2013 | WO2013045373A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/04/2013 | WO2013044816A1 Crystalline forms of azilsartan and preparation and uses thereof |
| 04/04/2013 | WO2013044736A1 Traditional chinese medicine composition for external use in treating xerophthalmia and the preparation method thereof |
| 04/04/2013 | WO2013044568A1 Method for testing drug for treating coronary artery disease and angina pectoris |
| 04/04/2013 | WO2013044511A1 Pharmaceutical composition containing riligustilide and use thereof |
| 04/04/2013 | WO2013014204A3 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 04/04/2013 | WO2013005698A9 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 04/04/2013 | WO2012174013A3 Treatment of cardiovascular disease, stroke, and inflammatory conditions |
| 04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
| 04/04/2013 | US20130085172 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | US20130085167 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 04/04/2013 | US20130085166 Formulations and uses of retinoic acid receptor selective agonists |
| 04/04/2013 | US20130085157 Arylsubstituted thiazolotriazoles and thiazoloimidazoles |
| 04/04/2013 | US20130085156 Novel 2-pyridinecarboxamide derivatives |
| 04/04/2013 | US20130085114 Method for treating varicocele or male infertility using anthocyanin extracted from black soybean |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | CA2850520A1 Aromatic-cationic peptides and methods for using same |
| 04/04/2013 | CA2850100A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | CA2850022A1 5 - benzylaminomethyl - 6 - aminopyrazolo [3,4-b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
| 04/04/2013 | CA2849782A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | CA2849000A1 Phenyl derivative |
| 04/04/2013 | CA2846200A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | CA2844581A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/04/2013 | CA2818944A1 Pyrazole compounds |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN103025329A Association of xanthine oxidase inhibitors and statins and use thereof |
| 04/03/2013 | CN103013806A Health-care therapeutic herbal vinegar |
| 04/03/2013 | CN103013754A Method for brewing health-care wine |
| 04/03/2013 | CN103013741A Preparation method of hawthorn health-care wine |
| 04/03/2013 | CN103012620A High-purity heparin benzyl ester salt and preparation method and application thereof |
| 04/03/2013 | CN103012618A Preparation method of switch type NO procedural donor |
| 04/03/2013 | CN103012543A 3 alpha,11 alpha-dihydroxy-23-formyl-lupin-20(29)-alkene-28-acid with anti-inflammatory action and preparation method of 3 alpha,11 alpha-dihydroxy-23-formyl-lupin-20(29)-alkene-28-acid. |
| 04/03/2013 | CN103012513A Preparation method and application of methyl-hydroxyl stilbene glycoside crystal |
| 04/03/2013 | CN103012427A Prasugrel hydrochloride ethanol solvate and preparation method thereof |
| 04/03/2013 | CN103012421A Isoquinoline drug, its preparation and application |
| 04/03/2013 | CN103012416A Method for preparing high-purity nalmefene hydrochloride |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012397A Pyrazolo quinolinone derivative and preparation method thereof as well as therapeutic application of derivative |
| 04/03/2013 | CN103012390A Indole derivatives as S1P1 receptor |
| 04/03/2013 | CN103012381A Benzofuran compound, preparation method thereof and application of benzofuran compound in preparation of antiarrhythmic drugs |
| 04/03/2013 | CN103012380A Chroman compound, and preparation method and application thereof |
| 04/03/2013 | CN103012376A Amide derivatives |
| 04/03/2013 | CN103012349A Crystal form C of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 04/03/2013 | CN103012345A Luteolin alpha crystal form substance, preparation method thereof as well as pharmaceutical composition and application thereof |
| 04/03/2013 | CN103012259A 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
| 04/03/2013 | CN103012254A Pyridone derivatives for modulating stress-activated protein kinase system |
| 04/03/2013 | CN103012182A N-acyl-sphingosine compound, preparation method and application of N-acyl neuro sphingosine compound |
| 04/03/2013 | CN103012142A (E)-4-(3,5-dihydroxystyryl)-2-phenyl chloroacetate compound and preparation method thereof |
| 04/03/2013 | CN103012141A (E)-3-hydroxy-5-(hydroxystyryl)-2-phenyl chloroacetate compound and preparation method thereof |
| 04/03/2013 | CN103007324A Indoor purely-natural Chinese herbal air-purifying agent |
| 04/03/2013 | CN103007291A Composition for treating eye diseases by double-target/multi-target small nucleic acid and applications of composition |
| 04/03/2013 | CN103007225A Pure traditional Chinese medicine composition for curing vital myocarditis |
| 04/03/2013 | CN103007217A Chinese medicinal composition for treating hypotension |
| 04/03/2013 | CN103007214A Chinese medicinal composition for treating palpitation |
| 04/03/2013 | CN103007201A Yixin Tongmai granules |
| 04/03/2013 | CN103007200A Medicament for treating coronary heart disease |
| 04/03/2013 | CN103007192A Chinese medicinal composition for treating thoracic obstruction |
| 04/03/2013 | CN103007185A Guanxinkang empirical formula |
| 04/03/2013 | CN103007179A Method for treating coronary heart disease angina pectoris by using traditional Chinese medicine |
| 04/03/2013 | CN103007156A Traditional Chinese medicine decoction for treating angina and preparation method thereof |
| 04/03/2013 | CN103007113A Traditional Chinese medicinal composition for treating phlebitis and method for preparing same |
| 04/03/2013 | CN103007105A Drug composition for curing piles |
| 04/03/2013 | CN103007098A Composite with functions of accelerating generation of nitric oxide and improving immunity and containing arginine, ginseng and coix seeds |
| 04/03/2013 | CN103007088A Bamboo tea detoxifying patch |
| 04/03/2013 | CN103007087A Medical vinegar for diabetes mellitus, hyperlipidemia, high cholesterol and recessive gallstones |
| 04/03/2013 | CN103007071A Hypertension-treating health-care tea with blood fat reducing and blood sugar reducing effects |
| 04/03/2013 | CN103007067A Chinese herbal preparation for treating primary hypotension and preparation method of preparation |
| 04/03/2013 | CN103007066A Chinese herbal soft capsules for treating primary hypotension and preparation method of soft capsules |
| 04/03/2013 | CN103007065A Chinese herbal preparation for treating primary hypotension and preparation method of preparation |
| 04/03/2013 | CN103007064A Traditional Chinese medicine (TCM) composition for treating cerebral posterior circulation ischemia |
| 04/03/2013 | CN103007062A Chinese medicinal preparation for treating cerebral thrombosis |
| 04/03/2013 | CN103007058A Medicine for treating diabetes, hypertension and rheumatoid diseases and preparation method thereof |
| 04/03/2013 | CN103007015A Traditional Chinese medicine composition for treating cerebral circulation insufficiency and preparation method thereof |
| 04/03/2013 | CN103007005A Chinese medicinal composition for treating heart disease |